Participant flow12

How many started, completed or left each group, period by period.

1 to 12 of 12

Period	Milestone	Group	Participants
Overall Study	STARTED	PEG-IFN 180 µg + Ribavirin 1200 mg	195
Overall Study	STARTED	PEG-IFN 180 µg + Ribavirin 1400/1600 mg	196
Overall Study	STARTED	PEG-IFN 360/180 µg + Ribavirin 1200 mg	393
Overall Study	STARTED	PEG-IFN 360/180 µg + Ribavirin 1400/1600 mg	391
Overall Study	COMPLETED	PEG-IFN 180 µg + Ribavirin 1200 mg	137
Overall Study	COMPLETED	PEG-IFN 180 µg + Ribavirin 1400/1600 mg	136
Overall Study	COMPLETED	PEG-IFN 360/180 µg + Ribavirin 1200 mg	273
Overall Study	COMPLETED	PEG-IFN 360/180 µg + Ribavirin 1400/1600 mg	266
Overall Study	NOT COMPLETED	PEG-IFN 180 µg + Ribavirin 1200 mg	58
Overall Study	NOT COMPLETED	PEG-IFN 180 µg + Ribavirin 1400/1600 mg	60
Overall Study	NOT COMPLETED	PEG-IFN 360/180 µg + Ribavirin 1200 mg	120
Overall Study	NOT COMPLETED	PEG-IFN 360/180 µg + Ribavirin 1400/1600 mg	125

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT00394277/flow